FDA Approves Drug for Crohn’s Disease
From Times Wire Reports
Sufferers of Crohn’s disease won a new treatment that promises to decrease the intestinal inflammation that causes much of the disorder’s misery.
The Food and Drug Administration approved Entocort EC, saying the capsule promises fewer side effects than other steroids, such as prednisone, that are used to treat Crohn’s.
Entocort EC capsules release the medication, known chemically as budesonide, once they reach the intestine. That means less of the steroidal drug is absorbed into the body than other Crohn’s treatments allow, the FDA said.
